Inactive Instrument

Calendar Biocept Inc Nasdaq

Equities

US09072V1052

Chart calendar Biocept Inc

1960c2.BdMfVEHvNdK9QT0WYLu_ZJtrqoUwuZ_mLhEZFW7Bnzc.VIAoFSSlAr3zMAtEKuuOF8Mi77RWyO7RZH4gJziqqn9qlkU6IqBzsd8PVg~d748d3561706bf6153dd90f06a52431e

Upcoming events on Biocept Inc

11/08/2024 Q2 2024 Earnings Release (Projected)

Past events on Biocept Inc

14/05/2024 Q1 2024 Earnings Release (Projected)
11/09/2023 12:00 H.C. Wainwright Global Investment Conference
30/08/2023 21:00 Business Update Call
14/08/2023 21:05 Q2 2023 Earnings Release
20/06/2023 14:00 Maxim Group Virtual Healthcare Conference
17/04/2023 21:10 Q4 2022 Earnings Release
28/11/2022 21:00 Q3 2022 Earnings Call
21/11/2022 21:05 Q3 2022 Earnings Release
10/11/2022 21:05 Interim 2022 Earnings Release
26/10/2022 22:30 LD Micro Main Event Conference
14/10/2022 18:00 Investor Meeting - Key Opinion Leader
07/06/2022 21:00 Business Update Call
10/05/2022 Q1 2022 Earnings Release (Projected)
06/04/2022 13:00 FY 2021 Earnings Release
10/01/2022 12:00 H.C. Wainwright BioConnect Conference
07/12/2021 San Antonio Breast Cancer Symposium
20/11/2021 00:30 Society for Neuro-Oncology Meeting
15/11/2021 21:30 Q3 2021 Earnings Call
15/11/2021 21:05 Q3 2021 Earnings Release
13/10/2021 19:00 LD Micro Main Event Conference

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
3,25
3,28
-0.78%
5,53
5,44
1.55%
27,5
21,2
29.39%
61,2
58,4
4.85%
25,9
39,4
-34.38%
EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-24,3
-24,3
0.06%
-23,1
-22,2
-3.79%
-15,5
-20,6
24.78%
-2,41
-1,44
-66.87%
-32,0
-17,6
-82.22%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-24,6
-24,5
-0.25%
-25,1
-24,2
-3.74%
-17,8
-22,8
22.03%
-2,70
-1,70
-58.59%
-32,2
-17,8
-80.78%
Net income
Million USD
Released
Forecast
Spread
-25,2
-25,1
-0.25%
-25,3
-24,3
-3.81%
-17,8
-22,8
22%
-2,82
-1,70
-65.93%
-32,1
-17,8
-80.08%
EPS
USD
Released
Forecast
Spread
-2 703
-2 856
5.36%
-366
-288
-27.08%
-45,0
-63,3
28.91%
-5,70
-3,60
-58.33%
-56,7
-31,4
-80.86%
Announcement Date28/03/1925/03/2029/03/2106/04/2217/04/23

Quarterly results

Fiscal PeriodDecember 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales
Million USD
Released
Forecast
Spread
12,0
9,74
23.69%
17,5
16,1
8.82%
13,9
11,1
25.49%
19,9
11,5
73.58%
10,6
12,5
-14.93%
5,59
7,86
-28.92%
-10,3
3,27
-414.96%
0,67
1,58
-57.46%
0,59
1,65
-64.3%
EBIT
Million USD
Released
Forecast
Spread
-1,75
-2,27
23.11%
0,50
0,96
-47.81%
-2,78
-2,86
3%
-2,71
-4,01
32.53%
-5,10
-2,65
-92.09%
-5,58
-5,32
-4.87%
-18,6
-4,17
-346.01%






Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-1,83
-2,27
19.6%
0,43
0,92
-53.54%
-2,85
-2,90
1.89%
-2,77
-4,09
32.36%
-5,25
-2,70
-94.81%
-5,55
-5,32
-4.27%
-18,6
-4,21
-342.82%






Net income
Million USD
Released
Forecast
Spread
-1,83
-2,27
19.6%
0,43
0,92
-53.54%
-2,97
-2,90
-2.42%
-2,77
-4,09
32.36%
-5,25
-2,70
-94.81%
-5,55
-5,32
-4.27%
-18,5
-4,21
-339.85%






EPS
USD
Released
Forecast
Spread
-15,3
-4,80
-218.75%
0,90
1,95
-53.85%
-5,40
-5,70
5.26%
-4,80
-7,20
33.33%
-9,30
-4,80
-93.75%
-9,90
-9,30
-6.45%
-32,7
-7,35
-344.9%






Announcement Date16/08/2115/11/2106/04/2223/05/2210/11/2221/11/2217/04/2310/05/2314/08/23